Table 2.
Average percentage of susceptibility of Enterobacterales to antibiotics in Saudi Arabia between 2013–2023.
| Antibiotic |
Escherichia coli (n = 50,589) |
Klebsiella pneumoniae (n = 18,539) |
Klebsiella aerogenes (n = 858) |
Klebsiella oxytoca (n = 739) |
Proteus mirabilis (n = 5604) |
Providencia stuartii (n = 1733) |
Morganella morganii (n = 1754) |
Enterobacter cloacae (n = 1363) |
Citrobacter freundii (n = 596) |
|---|---|---|---|---|---|---|---|---|---|
| Amikacin | 82.5 | 81.3 | 30 | 94.7 | 58 | 76.6 | 73 | 72.3 | 88.1 |
| Amoxicillin/ clavulanic acid |
58.8 | 52.5 | 12.2 | 33.3 | 49.9 | 19.6 | 24.4 | 40 | 9.1 |
| Ampicillin | 33.4 | 17.3 | 6.5 | 5.9 | 25.3 | 16.1 | 4.9 | 27 | 0 |
| Cefepime | 62.3 | 59.4 | 9.8 | 60.7 | 38.5 | 38.4 | 14.5 | 47.9 | 45.7 |
| Cefoxitin | 77.2 | 69.4 | 53.5 | 66.7 | 71.4 | 73.1 | 73.1 | 28 | 41.5 |
| Ceftazidime | 65.2 | 57.9 | 12.5 | 26 | 36.5 | 37.3 | 12.8 | 57.3 | 37.6 |
| Ceftriaxone | 50.9 | 44.1 | - | - | 20.2 | 54.5 | - | - | - |
| Cefuroxime | 46.4 | 43.8 | - | - | 27.4 | 27.3 | 0 | 45.5 | - |
| Ciprofloxacin | 58.5 | 59.9 | 11.1 | 11.9 | 35.6 | 18.7 | 38.4 | 70.2 | 54.2 |
| Colistin | 79.3 | 83.7 | 53.8 | 71.4 | 1.6 | 1.5 | 0 | 60.9 | 93.3 |
| Ertapenem | 82.4 | 65.7 | 66.7 | 100 | 72.8 | 77.2 | - | 87.5 | 85.7 |
| Gentamicin | 74.2 | 69.4 | 28 | 58.2 | 39.1 | 21.7 | 31.3 | 70.3 | 58.6 |
| Imipenem | 88.5 | 75.6 | 94.2 | 98.1 | 67.2 | 54.9 | 95.6 | 95.9 | 71 |
| Levofloxacin | 51.9 | 60.3 | 20.5 | 28.9 | 20 | 19.5 | 13.1 | 55.6 | 37.9 |
| Meropenem | 89.1 | 73.8 | 100 | 100 | 82.2 | 73.1 | 94.1 | 50 | 42.9 |
| Nitrofurantoin | 77.5 | 44.2 | 33.3 | 38.7 | 19.7 | 7 | 3 | 61 | 63.1 |
| Piperacillin/ tazobactam |
77.7 | 64.4 | 58.5 | 70.8 | 70.8 | 72 | 53.3 | 75.2 | 65.2 |
| Tigecycline | 85.4 | 76.4 | 91.7 | 100 | 0 | 48.4 | 50 | 82.6 | 91.7 |
| Trimethoprim/ sulfamethoxazole |
51.5 | 54.7 | 40 | 23.1 | 25.9 | 33 | 38.7 | 52.6 | 29.3 |